Tim Jatkoe - Concepedia

Concepedia

Author

Tim Jatkoe

Johnson & Johnson (United States)

Also Known As

Jatkoe, Tim, Tim Jatkoe

19

Publications

4.4K

Citations

10

H-Index

37

Concepts

All Affiliations

Johnson & Johnson (United States)Pfizer (United States)

TJ

About

Tim Jatkoe is an author at Johnson & Johnson (United States) specializing in medicine, molecular diagnostics, and gene expression.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	3.1K
2	Engineering	3	3	2.9K
3	Health Sciences	2	2	142
4	Cell Biology	2	2	2.8K
5	Hepatology	1	1	88

Tim Jatkoe

×

10

Publications

4.4K

Citations

10

H-Index

	Year	Citations
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer Yixin Wang, Jan G.M. Klijn, Yi Zhang, The Lancet Radiation OncologyBreast OncologyOncologyEngineeringDistant Metastasis	2005	2.7K
Gene Expression Profiles and Molecular Markers To Predict Recurrence of Dukes' B Colon Cancer Yixin Wang, Tim Jatkoe, Yi Zhang, Journal of Clinical Oncology	2004	459
MicroRNA Classifiers for Predicting Prognosis of Squamous Cell Lung Cancer Mitch Raponi, Lesley Dossey, Tim Jatkoe, Cancer Research	2009	403
Molecular Profiling of Carcinoma of Unknown Primary and Correlation With Clinical Evaluation Gauri R. Varadhachary, Dmitri Talantov, Martin N. Raber, Journal of Clinical Oncology	2008	237
The G0/G1 switch gene 2 is a novel PPAR target gene Fokko Zandbergen, Stéphane Mandard, Pascal Escher, Biochemical Journal	2005	232
Predicting Splice Variant from DNA Chip Expression Data Gang Ken Hu, Steven J. Madore, Brian Moldover, Genome Research EngineeringGeneticsSplice VariantGene CharacterizationGenomics	2001	120
A Quantitative Reverse Transcriptase-Polymerase Chain Reaction Assay to Identify Metastatic Carcinoma Tissue of Origin Dimitri Talantov, Jonathan Baden, Tim Jatkoe, Journal of Molecular Diagnostics OncologyMalignant DiseaseTumor HeterogeneityMedicinePathology	2006	105
Expression profiling and identification of novel genes in hepatocellular carcinomas Carrie R. Graveel, Tim Jatkoe, Steven J. Madore, Oncogene EngineeringHepatologyMedicinePathologyCancer Genomics	2001	88
Yeast homolog of human SAG/ROC2/Rbx2/Hrt2 is essential for cell growth, but not for germination: chip profiling implicates its role in cell cycle regulation Manju Swaroop, Yixin Wang, Paul Miller, Oncogene ChromatinYeast HomologCell RegulationCell DivisionGenetics	2000	65
Predictive biomarkers for treatment with amivantamab plus lazertinib among <i>EGFR</i>-mutated NSCLC in the post-osimertinib setting: Analysis of tissue IHC and ctDNA NGS. Benjamin Besse, Christina S. Baik, Melina E. Marmarelis, Journal of Clinical Oncology ImmunologyPathologyImmunotherapeuticsImmunotherapyBiomarker (Medicine)	2023	37

Page 1